Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation

Oxaliplatin (OXA) is a third-generation cisplatin analog that has been approved as first-line chemotherapy in combination with 5-fluorouracil (5-FU) for the treatment of resectable and advanced colorectal cancer. However, the therapeutic efficacy of oral OXA and 5-FU is limited by their low bioavail...

Descripción completa

Detalles Bibliográficos
Autores principales: Pangeni, Rudra, Choi, Sang Won, Jeon, Ok-Cheol, Byun, Youngro, Park, Jin Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138023/
https://www.ncbi.nlm.nih.gov/pubmed/27942212
http://dx.doi.org/10.2147/IJN.S121114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138023/
https://www.ncbi.nlm.nih.gov/pubmed/27942212
http://dx.doi.org/10.2147/IJN.S121114

Ejemplares similares